Idera Pharma (IDRA) Reports In-Line Q2 Loss

Idera Pharma (NASDAQ: IDRA) reported Q2 EPS of ($0.11), in-line with the analyst estimate of ($0.11).

For earnings history and earnings-related data on Idera Pharma (IDRA) click here.

You May Also Be Interested In

• Tesla to launch Cybercab in Austin this month - report
• Citi upgrades Bath & Body Works to Buy with $25 price target
• iQIYI (IQ) Misses Q2 EPS by 21c